Company
panthertx.com
A quantum leap forward in the fight against cancer
Also known as PanTher Therapeutics, PanTher Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- PanTher Therapeutics, Inc.
- panthertx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our mission is to redefine cancer treatment with therapeutics administered exclusively at the tumor site to transform clinical outcomes and minimize side effects.
Funding snapshot
- Total raised
- $16MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3M2025-03-14
Funding rounds
- Round, 2025
- $3M2025-03-14, SEC form D sold, 26 investors
- Round, 2023
- $2.7M2023-11-30, SEC form D sold, 28 investors
- Round, 2022
- $1.3M2022-12-05, SEC form D sold, 15 investors
- Round, 2022
- $1.1M2022-06-01, SEC form D sold, 17 investors
- Round, 2020
- $7.3M2020-05-27, SEC form D sold, 59 investors
- Round, 2019
- $209K2019-06-10, SEC form D sold, 15 investors
- Round, 2018
- $268K2018-08-07, SEC form D sold, 6 investors
- Round, 2016
- $35K2016-10-28, SEC form D sold, 1 investor
- Round, 2015
- $95K2015-06-01, SEC form D sold, 3 investors
Products
- Other
- PTM-101
Loading relationship preview